Market Tracker

03/01 12:44pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

1.30
Delayed Data
As of 12:29pm ET
 +0.009 / +0.70%
Today’s Change
1.01
Today|||52-Week Range
5.15
+20.28%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close1.29
Today’s open1.32
Day’s range1.26 - 1.33
Volume244,913
Average volume (3 months)418,820
Market cap$83.7M
Dividend yield--
Data as of 12:29pm ET, 03/01/2017

Growth & Valuation

Earnings growth (last year)+24.18%
Earnings growth (this year)+42.52%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+166.39%
P/E ratioNM
Price/Sales4.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...-0.16-2.58%
CASICASI Pharmaceuticals...+0.04+2.82%
AFMDAffimed NV+0.10+5.00%
ECYTEndocyte Inc+0.25+12.20%
Data as of 12:44pm ET, 03/01/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$22.4M
Annual profit (last year)-$30.6M
Net profit margin-136.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts